FTYCX
Price
$46.31
Change
-$0.37 (-0.79%)
Updated
Aug 15 closing price
Net Assets
10.99B
VSCPX
Price
$340.19
Change
-$1.26 (-0.37%)
Updated
Aug 15 closing price
Net Assets
154.18B
Interact to see
Advertisement

FTYCX vs VSCPX

Header iconFTYCX vs VSCPX Comparison
Open Charts FTYCX vs VSCPXBanner chart's image
FullerThaler Behavioral Sm-Cp Eq C
Price$46.31
Change-$0.37 (-0.79%)
VolumeN/A
Net Assets10.99B
Vanguard Small Cap Index InstlPlus
Price$340.19
Change-$1.26 (-0.37%)
VolumeN/A
Net Assets154.18B
FTYCX vs VSCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FTYCX vs. VSCPX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTYCX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 154B vs. FTYCX (11B). VSCPX pays higher dividends than FTYCX: VSCPX (1.39) vs FTYCX (0.00). FTYCX was incepted earlier than VSCPX: FTYCX (7 years) vs VSCPX (15 years). FTYCX (1.63) is less costly to investors than VSCPX (0.03). FTYCX is a more actively managed with annual turnover of: 41.00 vs. VSCPX (13.00). FTYCX has a lower initial minimum investment than VSCPX: FTYCX (1000) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 9.18 vs. FTYCX (3.23). FTYCX return over 5 years is better than : 79.20 vs. VSCPX (57.76).
FTYCXVSCPXFTYCX / VSCPX
Total Expense Ratio1.630.035,433%
Annual Report Gross Expense Ratio1.630.035,433%
Fund Existence7 years15 years-
Gain YTD5.8272.528231%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets11B154B7%
Annual Yield % from dividends0.001.39-
Returns for 1 year3.239.1835%
Returns for 3 years32.6920.50159%
Returns for 5 years79.2057.76137%
Returns for 10 yearsN/A113.19-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI5.921.27
+27.31%
Karyopharm Therapeutics Inc.
EWTX14.150.22
+1.58%
Edgewise Therapeutics
RYAN59.12-0.39
-0.66%
Ryan Specialty Holdings
MBINM25.19-0.18
-0.72%
Merchants Bancorp
ALT3.63-0.05
-1.36%
Altimmune